Free Account Opening + AMC Free Demat
Loading...

Dr Lalchandani Labs IPO vs Indo US BioTech IPO

Comparision between Dr Lalchandani Labs IPO and Indo US BioTech IPO.

IPO Details

Dr Lalchandani Labs IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Indo US BioTech IPO is a SME Fixed Price Issue proposed to list at BSE SME.

  Dr Lalchandani Labs IPO Indo US BioTech IPO
Logo Dr Lalchandani Labs IPO Logo Indo US BioTech IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME BSE SME
Lead Managers Navigant Corporate Advisors Ltd Swastika Investmart Ltd
Registrar Cameo Corporate Services Limited Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Dr Lalchandani Labs IPO is up to ₹4.20 Cr whereas the issue size of the Indo US BioTech IPO is up to ₹7.29 Cr. The final issue price of Dr Lalchandani Labs IPO is ₹30.00 per share and of Indo US BioTech IPO is ₹51.00 per share.

  Dr Lalchandani Labs IPO Indo US BioTech IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹30.00 per share ₹51.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 4000 shares 2000 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 14,00,000 shares 14,30,000 shares
Issue Size Total (Amount) up to ₹4.20 Cr up to ₹7.29 Cr

IPO Timetable

Dr Lalchandani Labs IPO opens on Apr 25, 2018, while Indo US BioTech IPO opens on Apr 30, 2018. The closing date of Dr Lalchandani Labs IPO and Indo US BioTech IPO is Apr 27, 2018, and May 03, 2018, respectively.

  Dr Lalchandani Labs IPO Indo US BioTech IPO
Anchor Bid Date
Issue Open Apr 25, 2018 Apr 30, 2018
Issue Close Apr 27, 2018 May 03, 2018
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Dr Lalchandani Labs IPO P/E ratio is , as compared to Indo US BioTech IPO P/E ratio of .

  Dr Lalchandani Labs IPO Indo US BioTech IPO
Financial
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lacs)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 376.39 366.45 187.16 168.93 165.22
Total Revenue 461.67 302.81 192.79 141.39 121.96
Profit After Tax 70.74 32.32 31.91 4.13 1.93
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lacs)
31-Mar-17 31-Mar-16 31-Mar-15 31-Mar-14 31-Mar-13
Total Assets 1,293.66 1,368.76 767.52 605.19 626.38
Total Revenue 2,457.79 1,914.53 1,966.07 1,485.50 1,493.84
Profit After Tax 64.99 35.99 49.59 25.96 29.94
Promoter Shareholding (Pre-Issue)
Promoter Shareholding (Post-Issue)
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Dr Lalchandani Labs IPO retail investors (RII) are offered 6,28,000 shares while in Indo US BioTech IPO retail investors are offered 6,28,000 shares. Qualified institutional buyers (QIB) are offered 0 shares in Dr Lalchandani Labs IPO and 0 shares in Indo US BioTech IPO.

  Dr Lalchandani Labs IPO Indo US BioTech IPO
Anchor Investor Reserveration
Market Maker Reserveration 72,000 shares 74,000 shares
QIB 0 shares 0 shares
NII 6,28,000 shares 6,78,000 shares
RII 6,28,000 shares 6,78,000 shares
Employee
Others
Total 13,28,000 shares 14,30,000 shares

Bids Received (Subscription)

Dr Lalchandani Labs IPO subscribed 4.96x in total, whereas Indo US BioTech IPO subscribed 19.74x.

  Dr Lalchandani Labs IPO Indo US BioTech IPO
QIB (times)
NII (times) 3.35x 19.52x
Big NII (times)
Small NII (times)
RII (times) 6.48x 19.87x
Employee (times)
Other (times)
Total (times) 4.96x 19.74x

Comments

Add a public comment...